Prophylactic Migraine Medications Other Than Topiramate
For episodic migraine prevention, start with propranolol, metoprolol, or timolol (beta-blockers) as first-line alternatives to topiramate, with amitriptyline or divalproex/valproate as equally effective first-line options. 1
First-Line Alternatives (Episodic Migraine)
The 2025 American College of Physicians guideline establishes clear first-line options beyond topiramate 1:
Beta-Blockers
- Propranolol, metoprolol, or timolol reduce migraine days by approximately 1.27 days per month compared to placebo 2
- These are established as effective based on high-quality evidence 1, 3
- Start low and titrate gradually to therapeutic doses
Antidepressants
- Amitriptyline reduces migraine days by 1.2 days per month 2
- Particularly useful in patients with comorbid depression, anxiety, or insomnia 4
- First-line status supported by multiple guidelines 1, 5
Antiepileptics
- Divalproex sodium or valproate are first-line alternatives 1, 3
- Critical caveat: Avoid in people of childbearing potential due to teratogenicity 1
- Must discuss pregnancy risks before prescribing
Calcium Channel Blockers
- Flunarizine reduces migraine days by 0.44 days per month 2
- Recommended as first-line in Taiwan and European guidelines 5
- Not available in all countries (including the US)
Second-Line Options
When first-line treatments fail or are not tolerated 1:
ACE Inhibitors and ARBs
- Lisinopril (ACE inhibitor)
- Candesartan or telmisartan (ARBs)
- Evidence is limited but these are reasonable alternatives 1, 6
SSRIs
- Fluoxetine has some supporting evidence 1
- Less robust data than other first-line agents
Advanced/Specialized Therapies
CGRP Monoclonal Antibodies
For patients who have failed 2-3 oral preventives, CGRP antibodies are highly effective 1, 4:
- Erenumab: Reduces migraine days by 1.0-2.5 per month 2
- Fremanezumab: Reduces migraine days by 1.3-3.8 per month 2
- Galcanezumab: Reduces migraine days by 1.1-3.7 per month 2
- Eptinezumab: Reduces migraine days by 0.7-3.2 per month 2
These are well-tolerated with minimal side effects and work even in patients who failed multiple oral preventives 2, 5
CGRP Receptor Antagonists (Gepants)
- Atogepant: Reduces migraine days by 0.7-2.4 per month 2
- Oral option with similar efficacy to monoclonal antibodies
- Effective in both episodic and chronic migraine 2
Chronic Migraine Specific Options
For chronic migraine (≥15 headache days/month) 4:
First-Line for Chronic Migraine
- OnabotulinumtoxinA (Botox): FDA-approved specifically for chronic migraine 4, 5
- CGRP monoclonal antibodies: Effective even with medication overuse 4, 2
- Topiramate: Remains an option but you're seeking alternatives
- Flunarizine: First-line in some guidelines 5
Practical Prescribing Algorithm
Start with oral first-line agents (propranolol, metoprolol, timolol, amitriptyline, or divalproex) 1
- Initiate at low dose and titrate gradually over 2-3 months 1
- Use headache diary to track response
If inadequate response after 2-3 months, switch to different first-line agent 1
After failing 2-3 oral preventives, consider:
Match medication to comorbidities 4:
- Depression/anxiety/insomnia → amitriptyline
- Hypertension → beta-blockers, ACE inhibitors, or ARBs
- Obesity → avoid amitriptyline; consider agents with weight loss profile
Critical Caveats
- Pregnancy/childbearing potential: Avoid valproate entirely; discuss risks of all medications before prescribing 1
- Medication overuse headache: Must be addressed before preventive therapy can be fully effective 4
- Cost considerations: Prescribe less costly medications first (oral agents before biologics) 1
- Combination therapy: Topiramate + amitriptyline shows no added benefit over monotherapy with increased side effects 1
- Trial duration: Give adequate trial of 2-3 months at therapeutic dose before declaring failure 1, 3